Trial Outcomes & Findings for Randomized Control Trial to Study the Efficacy of the Surgical Mask Versus the N95 Respirator to Prevent Influenza (NCT NCT00756574)
NCT ID: NCT00756574
Last Updated: 2018-10-29
Results Overview
Laboratory confirmed influenza
Recruitment status
COMPLETED
Study phase
NA
Target enrollment
447 participants
Primary outcome timeframe
one year
Results posted on
2018-10-29
Participant Flow
Participant milestones
| Measure |
1. Surgical
surgical mask
|
2. N95 Respirator
N95 respirator
|
|---|---|---|
|
Overall Study
STARTED
|
225
|
221
|
|
Overall Study
COMPLETED
|
212
|
210
|
|
Overall Study
NOT COMPLETED
|
13
|
11
|
Reasons for withdrawal
| Measure |
1. Surgical
surgical mask
|
2. N95 Respirator
N95 respirator
|
|---|---|---|
|
Overall Study
Withdrawal by Subject
|
9
|
7
|
|
Overall Study
Lost to Follow-up
|
4
|
4
|
Baseline Characteristics
Randomized Control Trial to Study the Efficacy of the Surgical Mask Versus the N95 Respirator to Prevent Influenza
Baseline characteristics by cohort
| Measure |
1. Surgical
n=225 Participants
surgical mask
|
2. N95 Respirator
n=221 Participants
N95 respirator
|
Total
n=446 Participants
Total of all reporting groups
|
|---|---|---|---|
|
Age, Categorical
<=18 years
|
0 Participants
n=5 Participants
|
0 Participants
n=7 Participants
|
0 Participants
n=5 Participants
|
|
Age, Categorical
Between 18 and 65 years
|
225 Participants
n=5 Participants
|
221 Participants
n=7 Participants
|
446 Participants
n=5 Participants
|
|
Age, Categorical
>=65 years
|
0 Participants
n=5 Participants
|
0 Participants
n=7 Participants
|
0 Participants
n=5 Participants
|
|
Age, Continuous
|
36.5 years
STANDARD_DEVIATION 10.6 • n=5 Participants
|
35.8 years
STANDARD_DEVIATION 10.6 • n=7 Participants
|
36.2 years
STANDARD_DEVIATION 10.6 • n=5 Participants
|
|
Sex: Female, Male
Female
|
212 Participants
n=5 Participants
|
208 Participants
n=7 Participants
|
420 Participants
n=5 Participants
|
|
Sex: Female, Male
Male
|
13 Participants
n=5 Participants
|
13 Participants
n=7 Participants
|
26 Participants
n=5 Participants
|
|
Region of Enrollment
Canada
|
225 participants
n=5 Participants
|
221 participants
n=7 Participants
|
446 participants
n=5 Participants
|
PRIMARY outcome
Timeframe: one yearLaboratory confirmed influenza
Outcome measures
| Measure |
1. Surgical
n=212 Participants
surgical mask
|
2. N95 Respirator
n=210 Participants
N95 respirator
|
|---|---|---|
|
Laboratory-confirmed Influenza Infection
|
50 participants
|
48 participants
|
SECONDARY outcome
Timeframe: one yearvisit to primary care MD
Outcome measures
| Measure |
1. Surgical
n=212 Participants
surgical mask
|
2. N95 Respirator
n=210 Participants
N95 respirator
|
|---|---|---|
|
Physician Visits for Respiratory Illness
|
13 participants
|
13 participants
|
SECONDARY outcome
Timeframe: Over entire study periodCough and fever
Outcome measures
| Measure |
1. Surgical
n=212 Participants
surgical mask
|
2. N95 Respirator
n=210 Participants
N95 respirator
|
|---|---|---|
|
Influenza-like Illness
|
9 participants
|
2 participants
|
SECONDARY outcome
Timeframe: over study periodAbsent from work because of flu-like illness
Outcome measures
| Measure |
1. Surgical
n=212 Participants
surgical mask
|
2. N95 Respirator
n=210 Participants
N95 respirator
|
|---|---|---|
|
Absenteeism
|
42 participants
|
39 participants
|
Adverse Events
Serious adverse events
Adverse event data not reported
Other adverse events
Adverse event data not reported
Additional Information
Results disclosure agreements
- Principal investigator is a sponsor employee
- Publication restrictions are in place